In this study, we identify IGF2BP2 as a novel downstream target of PRMT1 in HNSCC through integrated analysis of RNA‐seq, ATAC‐seq, and TCGA‐HNSCC data. Here, IGF2BP2 is linked to head and neck squamous cell carcinoma.